Future concepts in the medical therapy of benign prostatic hyperplasia.

  title={Future concepts in the medical therapy of benign prostatic hyperplasia.},
  author={David C Cuellar and Natasha Kyprianou},
  journal={Current opinion in urology},
  volume={11 1},
The standard medical therapy for symptomatic benign prostatic hyperplasia is still alpha-blockers and 5alpha-reductase inhibitors. Ongoing studies demonstrate the long-term safety and efficacy of these two classes of therapeutic approaches. Although there have been no new Food and Drug Administration approved medical therapies for the treatment of benign prostatic hyperplasia over the past year, interest in and the use of phytotherapeutic agents continues to increase. In this review, we will… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…